Open access · US-GOV via ClinicalTrials.gov Clinical trial

Targeting Endoplasmic Reticulum Stress in Aging- and Obesity-Induced Vascular Dysfunction

Authors not listed

Colorado State University · 2019

Loss of proteostasis Human Randomized controlled trial

Abstract

Aging and obesity are both risk factors for cardiovascular disease (CVD). One process that links both of these conditions to CVD is vascular dysfunction. Data from animal studies indicate that endoplasmic reticulum (ER) stress may play an important role in the development of endothelial dysfunction in aging and obesity. Therefore, the goal of this study is to investigate the relative contributions of aging and obesity on vascular dysfunction and ER stress. Additionally, this study will determine if taking an oral supplement for 8 weeks will improve vascular dysfunction and ER stress. Results from this study have the potential to identify a safe treatment option for improving vascular function in aging and obese populations.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2019). Targeting Endoplasmic Reticulum Stress in Aging- and Obesity-Induced Vascular Dysfunction. <em>Colorado State University</em>. https://clinicaltrials.gov/study/NCT04001647

Vancouver

Anonymous. Targeting Endoplasmic Reticulum Stress in Aging- and Obesity-Induced Vascular Dysfunction. Colorado State University. 2019.

BibTeX

@misc{anon2019Target, title = {Targeting Endoplasmic Reticulum Stress in Aging- and Obesity-Induced Vascular Dysfunction}, author = {Anonymous}, journal = {Colorado State University}, year = {2019}, }